+
 
For the best experience, open
m.thewire.in
on your mobile browser or Download our App.
You are reading an older article which was published on
Jun 11, 2021
  • health

US FDA Denies Emergency Use Approval to Bharat Biotech's Covaxin

This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.
A photograph tweeted by S. Jaishankar, showing Covaxin being sent to Paraguay. Photo: Twitter/@DrSJaishankar
A photograph tweeted by S. Jaishankar, showing Covaxin being sent to Paraguay. Photo: Twitter/@DrSJaishankar

This article has been removed following an ex parte injunction of a court in Telangana, delivered following a petition filed by Bharat Biotech Ltd.

Bharat Biotech has also filed a Rs 100 crore defamation case against The Wire, its editors, and 10 staffers and contributors.

The Wire will be fighting this injunction and defamation plaint.

Make a contribution to Independent Journalism
More in Recent :
World

India Takes Dig at US Over Student Arrests, Labels Human Rights Report ‘Deeply Biased’

 View More
facebook twitter